Target intelligence / Profile preview

Cyclin-G2 (CCNG2)

Target
CCNG2
Molecular classification
Other (member of cyclin family, not a receptor, enzyme, ion channel, transporter, or classical transcription factor)
01

Overview

Cyclin-G2 (CCNG2) is a protein encoded by the CCNG2 gene in humans and is part of the cyclin family. It is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces p53-dependent cell cycle arrest. Cyclin-G2 helps negatively regulate cell cycle progression, and, unlike Cyclin-G1, it contains a C-terminal PEST motif, making its expression tightly regulated during the cell cycle. Cyclin-G2 has been reported to be involved in growth regulation and is associated with suppression of Wnt/β-catenin signaling, leading to inhibition of cancer cell growth and migration. Mutations or expression changes in CCNG2 have been studied in various cancers, suggesting a potential but not yet well-established role as a tumor suppressor[1][2][3][6].

Other names
Cyclin G2CCNG2cyclin-G2cyclin G2
02

Biological functions

Cell cycle regulationNegative regulation of cell cycle progressionGrowth regulation
03

Disease associations

Cancer (including roles in breast, prostate, colorectal, ovarian, and brain cancer)Other (potential roles in congenital malformations)

Beyond the preview

Go deeper on Cyclin-G2 (CCNG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin-G2 (CCNG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call